City

Ann Arbor (1)

Wuhan (1)

Condition

Sarcoma Metastatic (2)

Neoplasms, Connective and Soft Tissue (1)

Sarcoma (1)

Sarcoma,Soft Tissue (1)

Soft Tissue Sarcoma (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

University of Michigan Rogel Cancer Center (1)

Wuhan Union Hospital, China (1)

Collaborator

AstraZeneca (1)

Janssen Scientific Affairs, LLC (1)

Intervention

adriamycin (1)

camrelizumab (1)

olaparib (1)

trabectedin (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

sarcoma metastatic

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Sarcoma, Sarcoma Metastatic Trial in Ann Arbor (Olaparib, Trabectedin)

Active, not recruiting

Sarcoma
Sarcoma Metastatic

Ann Arbor, Michigan

University of Michigan Rogel Cancer Center

Dec 20, 2022

Soft Tissue Sarcoma, Tumors, Connective and Soft Tissue, Sarcoma Metastatic Trial in Wuhan (Camrelizumab, Adriamycin)

Recruiting

Soft Tissue Sarcoma
+3 more

Wuhan, Hubei, China

Union Hospital，Tongji Medical College, Huazhong University of Sc

Jun 1, 2021